Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 15;2(6):675-676.
doi: 10.1016/j.jacasi.2022.09.006. eCollection 2022 Nov.

Third Generation P2Y12 Inhibition for East Asian ACS Patients: Are We Really Different?

Yann Shan Keh  1 , Derek P Chew  2 , Jack Wei Chieh Tan  1
Affiliations
Editorial

Third Generation P2Y12 Inhibition for East Asian ACS Patients: Are We Really Different?

Yann Shan Keh et al. JACC Asia. .
No abstract available

Keywords: East Asian; acute coronary syndrome; antiplatelet therapy; diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Dr Tan has received honoraria from AstraZeneca, Bayer, Amgen, Medtronic, Abbott Vascular, Biosensors, Alvimedica, Boehringer Ingelheim, and Pfizer; has received research and educational grants from Medtronic, Biosensors, Biotronik, Philips, Amgen, AZ, Roche, Otsuka, Terumo, and Abbott Vascular; and has received consulting fees from Elixir and CSL Behring. Dr Keh has received a modest education grant from AstraZeneca. Dr Chew has reported that he has no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–1057. - PubMed
    1. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–2015. - PubMed
    1. Park D.W., Kwon O., Jang J.S., et al. Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial. Circulation. 2019;140(23):1865–1877. - PubMed
    1. Goto S., Huang C.H., Park S.J., Emanuelsson H., Kimura T. Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome—randomized, double-blind, phase III PHILO study. Circ J. 2015;79(11):2452–2460. - PubMed
    1. Saito S., Isshiki T., Kimura T., et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J. 2014;78(7):1684–1692. - PubMed

Publication types

LinkOut - more resources